345 results on '"Pearle, Margaret"'
Search Results
2. Reply by Authors
3. Efficacy of Intramuscular Ketorolac for Preventing Renal Colic Post Stent Removal: Randomized Controlled Trial
4. MP14-15 PREDICTORS OF SUCCESSFUL SECOND LOOK FLEXIBLE NEPHROSCOPY AFTER PERCUTANEOUS NEPHROLITHOTOMY
5. PD34-02 NATURAL HISTORY OF RESIDUAL FRAGMENTS AFTER AGGRESSIVE URETEROSCOPY AND FRAGMENT RETRIEVAL
6. MP42-09 CHARACTERIZING AND CONTRASTING HEMORRHAGE FOLLOWING PERCUTANEOUS NEPHROLITHOTOMY AND ROBOTIC ASSISTED PARTIAL NEPHRECTOMY
7. MP03-11 PREDICTORS OF STONE FREE RATE FOLLOWING AGGRESSIVE URETEROSCOPY
8. PD34-03 COMPARISON OF STONE-RELATED EVENTS AFTER URETEROSCOPY IN PATIENTS WITH AND WITHOUT RESIDUAL FRAGMENTS
9. MP23-07 NATURAL HISTORY OF RESIDUAL FRAGMENTS AFTER URETEROSCOPY
10. PD59-10 IMPACT OF AN ENHANCED RECOVERY AFTER SURGERY PROTOCOL ON PATIENT SYMPTOMS IN THE INTERMEDIATE POST-OPERATIVE PERIOD AFTER URETEROSCOPY FOR STONES
11. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers
12. MP49-18 CLINICAL AND RADIOGRAPHIC OUTCOMES FOLLOWING SALVAGE TREATMENT FOR URETEROPELVIC JUNCTION OBSTRUCTION
13. PD45-02 NATURAL HISTORY OF RESIDUAL FRAGMENTS CONFIRMED BY COMPUTED TOMOGRAPHY AFTER URETEROSCOPY
14. Do Urinary Cystine Parameters Predict Clinical Stone Activity?
15. MP90-13 24 HOUR URINE UTILIZATION IN NEPHROLITHIASIS TREATMENT: RESULTS FROM M-STONE (MULTI-CENTER COLLABORATION TO STUDY TREATMENT OUTCOMES IN NEPHROLITHIASIS EVALUATION)
16. MP95-08 PRIMARY HYPERPARATHYROIDISM: A SOMETIMES ELUSIVE DIAGNOSIS
17. MP90-14 DOES SATURATION INDEX PREDICT STONE ACTIVITY IN PATIENTS WITH CALCIUM OXALATE NEPHROLITHIASIS?
18. MP68-13 OUTCOMES OF PATIENTS WITH RADIOGRAPHIC XANTHOGRANULOMATOUS PYELONEPHRITIS MANAGED WITH PERCUTANEOUS NEPHROLITHOTOMY
19. MP75-12 PROSPECTIVE EVALUATION OF STONE FREE RATES BY COMPUTED TOMOGRAPHY AFTER AGGRESSIVE URETEROSCOPY
20. Percutaneous Access to the Kidney
21. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
22. Is Ureteroscopy as Good as We Think?
23. V6-06 URINE ACIDITY IS THE MOST IMPORTANT FACTOR IN URIC ACID STONE FORMATION: AN ILLUSTRATION
24. PD31-07 COMPARISON OF POTASSIUM CITRATE, CITRIC ACID AND PLACEBO ON CALCIUM PHOSPHATE STONES RECURRENCE: PRELIMINARY RESULTS
25. MP58-06 PREDICTORS OF PROGRESSIVE STONE DISEASE IN CALCIUM PHOSPHATE STONE FORMERS
26. MP67-16 PREDICTIVE FACTORS OF STONE FORMATION IN PRIMARY HYPERPARATHYROIDISM PATIENTS
27. PD13-12 USING AN ELECTRONIC MEDICAL RECORD TO ASSESS PATIENT-REPORTED MORBIDITY AFTER URETEROSCOPY
28. MP75-15 THE CONSEQUENCES OF DELAYING STONE TREATMENT
29. MP41-14 IMPACT OF URINE PH ON URINARY SUPERSATUATION OF CALCIUM OXALATE
30. MP80-05 PREDICTORS OF SEPTIC SHOCK IN PATIENTS WITH OBSTRUCTIVE PYELONEPHRITIS DUE TO CALCULI
31. A Prospective, Multi-Institutional Study of Flexible Ureteroscopy for Proximal Ureteral Stones Smaller than 2 cm
32. Animal Protein and the Risk of Kidney Stones: A Comparative Metabolic Study of Animal Protein Sources
33. MP18-04 DO CYSTINE PARAMETERS PREDICT CLINICAL STONE ACTIVITY?
34. MP18-06 A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY OF FLEXIBLE URETEROSCOPY FOR PROXIMAL URETERAL STONES <2CM
35. MP73-03 CHARACTERIZATION AND RECURRENCE RATES OF FIRST TIME STONE FORMERS IN THE ERA OF CT
36. PD28-10 PREDICTORS OF SEPTIC SHOCK IN PATIENTS WITH OBSTRUCTIVE PYELONEPHRITIS DUE TO URETERAL CALCULI
37. PD37-03 PERCSAC: A NOVEL DEVICE TO PREVENT STONE FRAGMENT MIGRATION DURING PERCUTANEOUS LITHOTRIPSY
38. How Much is a Kidney Worth? Cost-Effectiveness of Routine Imaging After Ureteroscopy to Prevent Silent Obstruction
39. 1810 HOW MUCH IS A KIDNEY WORTH? COST-EFFECTIVENESS OF ROUTINE IMAGING AFTER URETEROSCOPY FOR PREVENTION OF SILENT OBSTRUCTION
40. Clinical Effectiveness Protocols for Imaging in the Management of Ureteral Calculous Disease: AUA Technology Assessment
41. 2245 THE IMPACT OF OBESITY ON COST AND PREVALENCE OF UROLITHIASIS
42. Residual Fragments Following Ureteroscopic Lithotripsy: Incidence and Predictors on Postoperative Computerized Tomography
43. Novel Iron Oxide Microparticles Used to Render Stone Fragments Paramagnetic: Assessment of Toxicity in a Murine Model
44. Postoperative Infection Rates in Low Risk Patients Undergoing Percutaneous Nephrolithotomy With and Without Antibiotic Prophylaxis: A Matched Case Control Study
45. In Vitro Comparison of Prototype Magnetic Tool with Conventional Nitinol Basket for Ureteroscopic Retrieval of Stone Fragments Rendered Paramagnetic with Iron Oxide Microparticles
46. 2124 IN VITRO COMPARISON OF PROTOTYPE MAGNETIC TOOL WITH CONVENTIONAL NITINOL BASKET FOR URETEROSCOPIC RETRIEVAL OF STONE FRAGMENTS RENDERED PARAMAGNETIC WITH IRON-OXIDE MICROPARTICLES
47. Calcium Phosphate Content Does Not Affect Stone-Free Rate After Percutaneous Nephrolithotomy
48. Cost-Effectiveness of Primary Prevention Strategies for Nephrolithiasis
49. 2147 EFFECT OF VARIOUS ANIMAL PROTEIN SOURCES ON URINARY STONE RISK FACTORS
50. Should We Change Our Prophylactic Antimicrobial Regimen for Prostate Biopsy?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.